Zhejiang Dayang Biotech Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 251.29 million compared to CNY 194.05 million a year ago. Revenue was CNY 251.29 million compared to CNY 194.05 million a year ago.

Net income was CNY 19.4 million compared to CNY 8.43 million a year ago. Basic earnings per share from continuing operations was CNY 0.2429 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.2429 compared to CNY 0.1 a year ago.